跳至主要内容
临床试验/NL-OMON21261
NL-OMON21261已完成不适用

A study of the effects of probenecid on the pharmacokinetics and pharmacodynamics of sorafenib (PROSORA-study)

Erasmus MC0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Erasmus MC
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age ≥ 18 years
  • 2. Histological or cytological confirmed diagnosis of mRCC, HCC or differentiated thyroid carcinoma

排除标准

  • 1. Use of drugs which may show an increased systemic exposure when taken concomitantly with probenecid. (see appendix C)
  • 2. Patients with known blood dyscrasias, uric acid kidney stones or until an acute gouty attack has subsided.

研究者

发起方
Erasmus MC

相似试验